Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

NORVIUM BIOSCIENCE

  • FDA Approval
  • Nov. 18, 2024, 09:58 UTC
  • 44
  • 0 comments

FDA approve CITALOPRAM HYDROBROMIDE

Comment Full text

AMNEAL PHARMS CO

  • FDA Approval
  • Nov. 18, 2024, 09:58 UTC
  • 41
  • 0 comments

FDA approve ROSUVASTATIN CALCIUM

Comment Full text

TARO

  • FDA Approval
  • Nov. 18, 2024, 09:58 UTC
  • 48
  • 0 comments

FDA approve CITALOPRAM HYDROBROMIDE

Comment Full text

ACELLA

  • FDA Approval
  • Nov. 18, 2024, 09:58 UTC
  • 43
  • 0 comments

FDA approve LACOSAMIDE

Comment Full text

EPIC PHARMA LLC

  • FDA Approval
  • Nov. 18, 2024, 09:58 UTC
  • 55
  • 0 comments

FDA approve CITALOPRAM HYDROBROMIDE

Comment Full text

RISING

  • FDA Approval
  • Nov. 18, 2024, 09:58 UTC
  • 39
  • 0 comments

FDA approve NATEGLINIDE

Comment Full text

SOMERSET THERAPS LLC

  • FDA Approval
  • Nov. 18, 2024, 09:58 UTC
  • 51
  • 0 comments

FDA approve MOXIFLOXACIN HYDROCHLORIDE

Comment Full text

INGENUS PHARMS LLC

  • FDA Approval
  • Nov. 18, 2024, 09:58 UTC
  • 50
  • 0 comments

FDA approve METAXALONE

Comment Full text

ACTAVIS MID ATLANTIC

  • FDA Approval
  • Nov. 18, 2024, 09:58 UTC
  • 50
  • 0 comments

FDA approve DICLOFENAC SODIUM

Comment Full text

FRESENIUS KABI USA

  • FDA Approval
  • Nov. 18, 2024, 09:58 UTC
  • 40
  • 0 comments

FDA approve THIAMINE HYDROCHLORIDE

Comment Full text
  • Previous
  • 313
  • 314
  • 315
  • 316
  • 317
  • Next

Search

News categories

  • Technical Exchange News(11504)
  • Event(3373)
  • SEC News(216324)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(137418)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin